The DASH® Rapid PCR System delivers best-in-class solutions to address traditional limitations of respiratory testing.
Previously clinicians and patients were forced to choose between two less-than-ideal options: 1) less accurate, low-cost rapid antigen tests or 2) slow and expensive PCR testing that does not provide results within a patient visit.
Now, clinicians no longer have to make that tradeoff, as the DASH® Rapid PCR system provides affordable, lab-quality results in 15 minutes at the point of care within a single patient visit.
The FDA-cleared, CLIA-waived DASH® SARS-CoV-2 & Flu A/B Test offers a combination of benefits for patients and providers that are unrivaled. With a speed that is typically only available with antigen tests, the DASH® SARS-CoV-2 & Flu A/B Test delivers gold standard PCR results within a single patient visit.
The DASH® Rapid PCR System offers the convenience of room temperature storage of cartridges and controls. It is intuitive to operate by non-laboratory personnel, requires no calibration or preventive maintenance, and is multiplex-capable in a single cartridge. Additionally, Nuclein is developing an extensive planned test menu including both viral and bacterial pathogens.
Contact your Henry Schein Sales Representative for ordering information on the DASH® Rapid PCR System.

DASH® SARS-CoV-2 & Flu A/B Test package insert.
Nuclein, LLC is an Austin, Texas-based company founded in 2017 with a vision to enable simple, affordable, rapid, and accurate testing for everyone. Its DASH® Rapid PCR System runs the FDA-cleared and CLIA-waived DASH® SARS-CoV-2 & Flu A/B Test and delivers lab-quality, point-of-care PCR results in 15 minutes. With a speed that is typically only available with antigen tests, the DASH® Rapid PCR System was designed to offer low-cost, highly sensitive and specific results, with robust multiplexing across various sample types, and requires less than one minute of hands-on time.